Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma

Figure 3

Survival analysis of high- and low-risk patients and calculation of AUC values for such scoring methods. (a) Kaplan-Meier curve indicates the significant difference between the two subgroups. (b) Demonstration of survival status for patients with different scores. (c) PCA analysis. (d) AUCs for this risk score method at 1, 3, and 5 years.

(a)

(b)

(c)

(d)